Home » Stocks & shares » Industries » Health & pharmaceuticals

Health & pharmaceuticals news

Mediclinic’s full-year loss widens as the hospital operator records write-downs
2nd June
  • Mediclinic's net full-year loss climbs to £315 million versus £151 million last year.
  • The hospital operator posts a 5% growth in full-year revenue to £3.08 billion.
  • The British company writes down its equity investment in Spire by £10 million.

Features & analysis

Latest Health & pharmaceuticals news

21st May
AstraZeneca signs first agreements to deliver at least 400 million doses of COVID-19 vaccine
20th May
U.S. FDA approves AstraZeneca and Merck’s Lynparza as a treatment for prostate cancer
18th May
Moderna CEO: ‘Could not be happier’ with coronavirus vaccine data
15th May
Aurora Cannabis’ quarterly loss contracts as consumers stockpile ahead of lockdown
14th May
3M reports an 11% decline in sales in April as Coronavirus shuts factories
14th May
SmileDirectClub’s net loss widens in Q1 as Coronavirus weighs on performance
11th May
Cardinal Health climbs 7.7% on stronger than expected earnings and revenue in Q3
8th May
Siemens’ shareholders’ net profit tanks 64% as Coronavirus weighs on performance
7th May
Peloton’s revenue climbs 66% on greater demand for fitness equipment in Q3
6th May
CVS Health posts an upbeat financial report as customers stockpiled ahead of COVID-19
5th May
DuPont swings to a £495 million loss in Q1 as Coronavirus weighs on performance
5th May
Tenet Healthcare records stronger than expected profit in Q1 on a tax benefit from the CARES act
2nd May
Gilead’s Remdesivir gets emergency use authorization from the FDA to treat COVID-19
1st May
Clorox’s quarterly sales surge 15% as Coronavirus fuels demand for cleaning products
1st May
Amgen says it will test Otezla for COVID-19 as it posts an upbeat Q1 earnings report
29th April
General Electric posts an 8% lower revenue in Q1 due to Coronavirus restrictions
28th April
Merck & Co. reports a 10% higher profit in Q1 on solid demand for its cancer drug
1 2 3 4 5 6 7 8 9 54

Investing is speculative. When investing your capital is at risk. This site is not intended for use in jurisdictions in which the trading or investments described are prohibited and should only be used by such persons and in such ways as are legally permitted. Your investment may not qualify for investor protection in your country or state of residence, so please conduct your own due diligence. This website is free for you to use but we may receive commission from the companies we feature on this site. Click here for more information.